Department of Pharmaceutical Technology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
J Pharm Pharmacol. 2012 Jul;64(7):919-30. doi: 10.1111/j.2042-7158.2012.01474.x. Epub 2012 Mar 27.
This review focuses on the evolution and current status of biorelevant media and hydrodynamics, and discusses the usefulness of biorelevant performance testing in the evaluation of specific dosage form related lumenal processes.
During the last 15 years our knowledge of the gastrointestinal environment (including the lower gut) has improved dramatically and biorelevant media composition and, to a lesser extent, biorelevant hydrodynamics, have been refined. Biorelevant dissolution/release testing is useful for the evaluation of formulation and food effects on plasma levels after administration of immediate release dosage forms containing low solubility compounds and after administration of extended release products. Lumenal disintegration times of immediate release dosage forms and the bile acid sequestering activity of resins in the lumen can also be successfully forecasted with biorelevant in vitro testing.
Biorelevant in-vitro performance testing is an important tool for evaluating intralumenal dosage form performance. Since the formulation of new active pharmaceutical ingredients for oral delivery is more challenging than ever before, efforts to improve the predictability of biorelevant tests are expected to continue.
本综述重点介绍生物相关介质和流体动力学的发展和现状,并讨论生物相关性能测试在评价特定剂型相关腔道过程中的有用性。
在过去的 15 年中,我们对胃肠道环境(包括下消化道)的了解有了显著提高,生物相关介质的组成以及在较小程度上的生物相关流体动力学得到了改进。生物相关溶出/释放测试对于评价含有低溶解度化合物的即释剂型和缓控释产品给药后的制剂和食物对血浆水平的影响是有用的。即释剂型的腔内崩解时间和腔内树脂的胆汁酸螯合活性也可以通过生物相关的体外测试成功预测。
生物相关的体外性能测试是评估腔内剂型性能的重要工具。由于口服新的活性药物成分的制剂比以往任何时候都更具挑战性,因此预计将继续努力提高生物相关测试的可预测性。